View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 9, 2018

Baxter to acquire two Mallinckrodt’s surgical products for $185m

Medical products firm Baxter International has signed an agreement to purchase RECOTHROM and PREVELEAK surgical products from Mallinckrodt for a total consideration of around $185m, with $153m upfront.

Medical products firm Baxter International has signed an agreement to purchase RECOTHROM and PREVELEAK surgical products from Mallinckrodt for a total consideration of around $185m, with $153m upfront.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

The acquisition is expected to bolster Baxter’s surgical solutions portfolio for addressing intraoperative bleeding and expanding options for surgeons.

RECOTHROM is a thrombin-based topical product designed to assist haemostasis in case of available access to oozing and minor bleeding, and when control of bleeding by conventional surgical methods is ineffective or impractical in adults and paediatrics aged one month or above.

PREVELEAK is a surgical sealant indicated for the mechanical closing of suture holes to obtain adjunctive haemostasis in surgical vascular reconstructions.

The total sales of these products were reported to be around $56m in the 12 months before 29 September 2017.

“The total sales of these products were reported to be around $56m in the 12 months before 29 September 2017.”

Baxter Advanced Surgery business president Wil Boren said: “As a leading provider of advanced haemostats and sealants, Baxter is focused on continually identifying solutions to help meet surgeons’ varying needs.

“We are excited about the addition of RECOTHROM to help surgeons address less severe intraoperative bleeding and PREVELEAK to complement Baxter’s existing portfolio of sealants for cardiovascular and other surgical specialties.”

Mallinckrodt will, however, retain another fibrin sealant product RAPLIXA, and intends to discontinue its marketing after closing the deal with Baxter.

The deal is subject to customary closing conditions and is expected to be concluded in the first half of this year.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network